The increased likelihood of malignant behavior in pleomorphic xanthoastrocytoma and in BRAF p.V600E mutated tumors with CDKN2A deletion has led to a debate regarding the prognostic significance of BRAF p.V600E alone [101]. This evidence concerns the gene BRAF and pleomorphic xanthoastrocytoma.